Scorpion Therapeutics

Boston, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Jul 2024

Series C

Biotechnology Health Care Life Science Oncology Precision Medicine

Top Investors

Lightspeed Venture PartnersJanus Henderson InvestorsWellington ManagementOrbiMedAbingworth

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scorpion Therapeutics

Who are Scorpion Therapeutics's investors?

Scorpion Therapeutics's investors include Lightspeed Venture Partners, Janus Henderson Investors, Wellington Management, OrbiMed, Abingworth.

Where is Scorpion Therapeutics headquartered?

Scorpion Therapeutics is headquartered in Boston, United States.

What does Scorpion Therapeutics do?

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

What stage is Scorpion Therapeutics at?

Scorpion Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 16, 2024.

MLA

"Scorpion Therapeutics — Funding & Investors." VCBacked, July 16, 2024, https://www.vcbacked.co/company/scorpion-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Scorpion Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/scorpion-therapeutics

Wikipedia (cite web)

{{cite web |title=Scorpion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scorpion-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 16, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.